Line 10679 was developed in the laboratory of Chenjian Li at Cornell. The model was created through pronuclear injection of human gene SNCA with the E46K mutation into NTac:SD zygotes. Founder line 70 was bred to NTac:SD. The colony is maintained by mating a wild type female with a hemizygous male to produce hemizygous pups. Taconic received stock from Cornell in 2010 and derived the rats through embryo transfer derivation.
Cannon, J.R., et al., Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to 3 mitochondrial impairment. Exp Neurol. 2012 Nov 12;240C:44-56. doi: 10.1016/j.expneurol.2012.11.007. [Epub ahead of print]
Terms of Use:
Rats may be cryo-recovered at Taconic. Nonprofit users may access rats for research purposes under a simple label license (no signatures required). For-profit users must first execute a license agreement with Cornell University.
Conditions of Use for Parkinson's Disease Rat Models for Nonprofit Users:
The Parkinson's Disease Rat Models (Model), Taconic Models 10678, 10679, 10680, and 10681, are produced and distributed under rights to patents and/or intellectual property owned by Cornell University (Cornell). Taconic has rights to distribute the Model on behalf of Cornell. Cornell maintains ownership of the Model and permits the sale of such rats to each Buyer that agrees to the following Terms and Conditions of the Sale and following terms of use:
For licensing information, contact:
Cornell Center for Technology Enterprise and Commercialization
Attention: Executive Director
395 Pine Tree Road, Suite 310
Ithaca, NY 14850
Fax: 607-254-5454
Phone: 607-254-5236
Email: cctec-contracts@cornell.edu
Cite: Docket D4184 (LRRK2) and D5203 (alpha-synuclein)
Welcome! Tell us a little about yourself